Among those with advanced gastric cancer, oral Liporaxel showed superior overall survival outcomes versus IV Liporaxel as a ...

Dr. Eric K. Singhi shares his insights into the advantages of the subcutaneous formulation of Opdivo versus the IV version ...

The Food and Drug Administration said Tuesday that no IV glutathione product in the Philippines was approved for skin whitening.

Oral paclitaxel matched IV in progression-free survival but outperformed it in overall survival for second-line advanced gastric cancer.

Intravenous (IV) thrombolysis with recent lumbar puncture is a relative contraindication due ... To our knowledge, there are no reported cases of successful IV thrombolysis after cervical epidural ...

A monthly 10 mg/mL maintenance dose of Leqembi had the same effects on mild Alzheimer’s symptoms as biweekly dose, research ...

Although this is true for many people with iron deficiency, it can be much more complicated. When determining which iron therapy—oral or intravenous (IV)—is right for you, it is important to consider ...

The phase 3 CheckMate-67T trial confirmed noninferiority in pharmacokinetics and comparable efficacy to IV nivolumab ... for subcutaneous injection across approved nivolumab (Opdivo) indications ...

Opdivo was previously only available as a solution for intravenous (IV) infusion. The approval of Opdivo Qvantig was supported by data from the randomized, open-label phase 3 CheckMate-67T study ...